Artificial Intelligence in Diabetes Management Market by Device (Glucose Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices, and Other Devices) and by Technique Type (Case-based Reasoning and Intelligent Data Analysis): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 – 2024

Global artificial intelligence in diabetes management market expected to reach approximately USD 1422.52 million by 2024, growing at a CAGR of around 47.23% between 2018 and 2024. Diabetes is a group of metabolic disorder characterized by lack of production of a sufficient amount of insulin by human pancreas.

Request Brochure Request Discount

14-Sep-2018 | Number of pages: 160 | Report Code: ZMR-3361 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the artificial intelligence in diabetes management market on a global and regional level. The study provides historical data from 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the artificial intelligence in diabetes management market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the artificial intelligence in diabetes management market on a global level.

In order to give the users of this report a comprehensive view of the artificial intelligence in diabetes management market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a customer and region segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global Artificial Intelligence in Diabetes Management Market

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, regional expansion of major participants involved in the market on the global and regional basis. 

The study provides a decisive view of the artificial intelligence in diabetes management market by segmenting the market based on customer and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. 

Based on devices, the global artificial intelligence in diabetes management market is segmented into four types: glucose monitoring devices, diagnostic devices, insulin delivery devices, and other devices. Based on techniques, the market is segmented into two types case-based reasoning and intelligent data analysis. 

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further divided into major countries including the U.S. Germany, France, the UK, China, Japan, India, and Brazil. This segmentation includes demand for artificial intelligence in diabetes management based on individual segment and applications in all the regions and countries.

The report covers detailed competitive outlook including the market share, reimbursement policy, and company profiles of the key participants operating in the global artificial intelligence in diabetes management market include Apple Inc., Diabnext, Glooko Inc., Google Inc., IBM Corporation, Tidepool, and Vodafone Group Plc.

This report segments the global artificial intelligence in diabetes management market as follows:

Global Artificial Intelligence in Diabetes Management Market: Device Type Analysis

  • Glucose Monitoring Devices
  • Diagnostic Devices
  • Insulin Delivery Devices
  • Other Devices

Global Artificial Intelligence in Diabetes Management Market: TechniqueType Analysis

  • Case-based Reasoning
  • Intelligent Data Analysis

Global Artificial Intelligence in Diabetes Management Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports

Pain Management Therapeutics Market by Drug Class (Anesthetics, NSAIDS, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic Analgesics, and Opioids (Tramadol, Oxycodone, Hydrocodone, and Others)); by Indication (Neuropathic Pain, Arthritic Pain, Cancer Pain, Post-operative Pain, Chronic Back Pain, Fibromyalgia, and Migraine), and by Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, and Online Pharmacy): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 130 | Report Code: ZMR-3373 | Report Format:

The report covers forecast and analysis for the pain management therapeutics market on a global and regional level. The study provides historic data for 2015, 2016, and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the pa...Read More

Healthcare Regulatory Affairs Outsourcing Market by Services (Regulatory Writing and Publishing, Regulatory Submissions, Clinical Trial Applications and Services Registrations, Regulatory Consulting and Legal Representation, and Other Regulatory Affairs) and by End-User (Mid-Size Pharmaceutical Companies, Large Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, and Food and Beverage Companies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3369 | Report Format:

The report covers forecast and analysis for the healthcare regulatory affairs outsourcing market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Billion). The study includes drivers and restraints fo...Read More

Thrombosis Drug Market by Drug Class (Factor Xa Inhibitor, Low Molecular Weight Heparin, and P2Y12 Platelet Inhibitor), by Indications (Pulmonary Embolism, Atrial Fibrillation, and Deep Vein Thrombosis), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017- 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3363 | Report Format:

The report covers forecast and analysis for the thrombosis drug market on a global and regional level. The study provides historical data from 2015 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the thrombosis drug market along...Read More

Pharmaceutical Continuous Manufacturing Market by Application (Active Pharmaceutical Ingredient, Biologics, and Dry Powders), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by End-users (Pharmaceutical Companies and Contract Manufacturing Organization): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024

Sep-2018 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3314 | Report Format:

The report covers forecast and analysis for the pharmaceutical continuous manufacturing market on a global and regional level. The study provides historic data for 2016 and 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for th...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.